P3.02b-077 Osimertinib Expanded Access Program for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLCEdgardo Santos,Barry Kaplan,Eli Kirshner,Elisabeth Croft,Lecia Sequist, Lea Burke,Jiefen Munley,Geoffrey OxnardJournal of Thoracic Oncology(2017)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要